NCI Immunotherapy Fellowship

One Year at NCI Center for Cancer
Research • Begins July 2023
Application Period: Aug. 1–Sept. 6, 2022

Conducted at the National Cancer Institute's Center for Cancer Research in Bethesda, MD, this 1-year program allows the fellow to have exposure to multiple clinical immunotherapeutic approaches and also to key opinion leaders in the field of clinical immunotherapy. This fellowship provides opportunities to understand how to design, write and run clinical trials, how to treat patients, how manage toxicities, as well as opportunities to work with multiple experimental agents.

Eligibility Criteria

• Able to relocate to Bethesda, MD for the duration of the fellowship
• Trained in Medical Oncology, Hematology, Pediatric Oncology, Radiation Oncology, or Surgical Oncology
• Strong interest in learning about immunotherapy
• Preference is given to those with an academic interest
• Open to U.S. and non-U.S. trained physicians (the latter requires ECFMG certification and completion of USMLE Step 1, 2, and 3)

Benefits

• Provides opportunities to understand how to design, write, and run clinical trials, how to treat patients, how to manage toxicities, as well as opportunities to work with multiple experimental agents
• Work with internationally recognized experts in immunotherapy
• Learn management of immune-related adverse events
• Develop experience in writing and running immunotherapy clinical trials
• Develop experience with a wide array of immunotherapy approaches
  • Cellular therapy (e.g., CAR-T or TCR transgenic approaches)
  • Combination immunotherapy approaches
  • Immune checkpoint inhibitors
  • Immunocytokines
  • Therapeutic vaccines
• Possibilities for attending and presenting at national/international meetings
• Attend and participate in regularly scheduled NIH immunotherapy conferences
• Make a difference in the lives of patients with cancer at the largest hospital in the world devoted solely to research
• Salary is based on applicable laws, regulations, and policies

Application Period Closes Sept. 6, 2022

1. Curriculum Vitae
   • CV or NIH Biosketch or equivalent (maximum 5 pages)
2. Statement of purpose
   • Please tell us why you are interested in this fellowship in 500 words or less. Please include:
     • A description of your research interests and goals and how these relate to cancer immunotherapy clinical trials and clinical trial development.
     • A description of your career path up to this point, as well as insight into your short- and long-term goals, and how this fellowship will help you achieve those goals.
3. Three personal references
   • Three current and original letters of reference must be submitted by individuals in the scientific/academic community who have knowledge of your scientific accomplishments, motivation, and skills.
4. Documentation of board eligibility status or certification status
   • For foreign medical graduates, ECFMG certification and USMLE Step 1, 2, and 3 must be completed.

If you have questions about the SITC-NCI Fellowship, please contact the SITC Education team.